A 17-year-old female presents with the absence of menstruation by the age of 17. She reports no prior history of menstrual bleeding. Sarah had normal developmental milestones during childhood, but there is a notable lack of breast development corresponding to Tanner Stage 1. Her mother attained menarche at age 13, and there is no family history of genetic disorders or early menopause. Her past medical history is unremarkable, with no chronic illnesses or previous surgeries. On physical examination, Sarah is short in stature, measuring 143 cm in height and weighing 38 kg. Secondary sexual characteristics are absent, with no breast development or significant pubic and axillary hair, consistent with Tanner Stage 1. Additional features include a webbed neck, low posterior hairline, and a broad chest with widely spaced nipples. A pelvic examination reveals no palpable ovaries. A karyotype analysis confirmed the diagnosis. Which of the following treatment options is appropriate for this patient?
